Occudo Quantitative Strategies LP Tcr2 Therapeutics Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.86 - $3.75 $32,497 - $65,520
-17,472 Reduced 34.75%
32,803 $59,000
Q2 2022

Aug 15, 2022
SELL
$2.11 - $2.94 $35,403 - $49,330
-16,779 Reduced 25.02%
50,275 $146,000
Q1 2022

May 16, 2022
SELL
$2.4 - $4.71 $170,152 - $333,924
-70,897 Reduced 51.39%
67,054 $185,000
Q4 2021

Feb 14, 2022
BUY
$4.58 - $8.34 $631,815 - $1.15 Million
137,951 New
137,951 $643,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email